Considering that KP metabolites downstream IDO are related to the immune modulation and several glioma hallmarks, this study was focused on understanding the contribution of KYNU in GBM and how it influences the anti-tumor immune response and consequently the survival of glioma patients through a bioinformatic approach. Here, IDO1 is linked to neoplasm.